{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T04:20:49Z","timestamp":1789186849399,"version":"build-2803163510"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,7,15]],"date-time":"2008-07-15T00:00:00Z","timestamp":1216080000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1186\/1471-2393-8-24","type":"journal-article","created":{"date-parts":[[2008,7,15]],"date-time":"2008-07-15T18:13:47Z","timestamp":1216145627000},"source":"Crossref","is-referenced-by-count":25,"title":["Drug-prescribing patterns during pregnancy in the tertiary care hospitals of Pakistan: a cross sectional study"],"prefix":"10.1186","volume":"8","author":[{"given":"Dileep K","family":"Rohra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirmal","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed I","family":"Azam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazir A","family":"Solangi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahida","family":"Memon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul M","family":"Shaikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nusrat H","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,7,15]]},"reference":[{"key":"24_CR1","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1177\/0091270003254794","volume":"43","author":"DM Benjamin","year":"2003","unstructured":"Benjamin DM: Reducing medication errors and increasing patient safety: case studies in clinical pharmacology. J Clin Pharmacol. 2003, 43: 768-783.","journal-title":"J Clin Pharmacol"},{"key":"24_CR2","first-page":"335","volume":"32","author":"S Kacew","year":"1994","unstructured":"Kacew S: Fetal consequences and risks attributed to the use of prescribed and over-the-counter (OTC) preparations during pregnancy. Int J Clin Pharmacol Ther. 1994, 32: 335-243.","journal-title":"Int J Clin Pharmacol Ther"},{"key":"24_CR3","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1056\/NEJM199804163381607","volume":"338","author":"G Koren","year":"1998","unstructured":"Koren G, Pastuszak A, Ito S: Drugs in pregnancy. N Eng J Med. 1998, 338: 1135-1137. 10.1056\/NEJM199804163381607.","journal-title":"N Eng J Med"},{"key":"24_CR4","first-page":"32","volume":"13","author":"LT De Jong-van den Berg","year":"1991","unstructured":"De Jong-van den Berg LT, Berg Van den PB, Haaijer-Ruskamp FM, Dukes MN, Wesseling H: Investigating drug use in pregnancy. Methodological problems and perspectives. Pharm Weekbl Sci. 1991, 13: 32-38.","journal-title":"Pharm Weekbl Sci"},{"key":"24_CR5","doi-asserted-by":"publisher","first-page":"505","DOI":"10.2515\/therapie:2003082","volume":"58","author":"MN Beyens","year":"2003","unstructured":"Beyens MN, Guy C, Ratrema M, Ollagnier M: Prescription of drugs to pregnant women in France: the HIMAGE study. Therapie. 2003, 58: 505-511.","journal-title":"Therapie"},{"key":"24_CR6","doi-asserted-by":"crossref","unstructured":"Medication during pregnancy: an intercontinental cooperative study. Collaborative Group on Drug Use in Pregnancy (C.G.D.U.P.). Int J Gynaecol Obstet. 1992, 39: 185-196. 10.1016\/0020-7292(92)90656-4.","DOI":"10.1016\/0020-7292(92)90656-4"},{"key":"24_CR7","unstructured":"Pakistan Drug Index: Ready reference handbook of all medicines available in Pakistan. 2007"},{"key":"24_CR8","doi-asserted-by":"publisher","first-page":"277","DOI":"10.4103\/0019-5359.26602","volume":"60","author":"R Sharma","year":"2006","unstructured":"Sharma R, Kapoor B, Verma U: Drug utilization pattern during pregnancy in North India. Indian J Med Sci. 2006, 60: 277-287.","journal-title":"Indian J Med Sci"},{"key":"24_CR9","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1097\/00001648-200107000-00017","volume":"12","author":"M Rockenbauer","year":"2001","unstructured":"Rockenbauer M, Olsen J, Czeizel AE, Pedersen L, S\u00f8rensen HT, EuroMAP Group: Recall bias in a case-control surveillance system on the use of medicine during pregnancy. Epidemiology. 2001, 12: 461-466. 10.1097\/00001648-200107000-00017.","journal-title":"Epidemiology"},{"key":"24_CR10","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2165\/00002018-199614020-00001","volume":"14","author":"R Sannerstedt","year":"1996","unstructured":"Sannerstedt R, Lundborg P, Danielsson BR, Kihlstr\u00f6m I, Alv\u00e1n G, Prame B, Ridley E: Drugs during pregnancy: an issue of risk classification and information to prescribers. Drug Saf. 1996, 14: 69-77.","journal-title":"Drug Saf"},{"key":"24_CR11","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1016\/S0140-6736(00)03209-8","volume":"356","author":"I Lacroix","year":"2000","unstructured":"Lacroix I, Damase-Michel C, Lapeyre-Mestre M, Montastruc JL: Prescription of drugs during pregnancy in France. Lancet. 2000, 356: 1735-1736. 10.1016\/S0140-6736(00)03209-8.","journal-title":"Lancet"},{"key":"24_CR12","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/j.1365-3016.2003.00542.x","volume":"18","author":"WO Cooper","year":"2004","unstructured":"Cooper WO, Hickson GB, Ray WA: Prescriptions for contraindicated category X drugs in pregnancy among women enrolled in TennCare. Paed Perinatal Eidemiol. 2004, 18: 106-111. 10.1111\/j.1365-3016.2003.00542.x.","journal-title":"Paed Perinatal Eidemiol"},{"key":"24_CR13","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1089\/jwh.2005.14.401","volume":"14","author":"EH Riley","year":"2005","unstructured":"Riley EH, Fuentes-Afflick E, Jackson RA, Escobar GJ, Brawarsky P, Schreiber M, Haas JS: Correlates of prescription drug use during pregnancy. J Women's Health. 2005, 14: 401-409. 10.1089\/jwh.2005.14.401.","journal-title":"J Women's Health"},{"key":"24_CR14","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2165\/00002018-200023030-00006","volume":"23","author":"A Addis","year":"2000","unstructured":"Addis A, Sharabi S, Bonati M: Risk classification systems for drug use during pregnancy: are they a reliable source of information?. Drug Saf. 2000, 23: 245-253. 10.2165\/00002018-200023030-00006.","journal-title":"Drug Saf"},{"key":"24_CR15","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/pds.770","volume":"12","author":"B Das","year":"2003","unstructured":"Das B, Sarkar C, Datta A, Bohra S: A study of drug use during pregnancy in a teaching hospital in western Nepal. Pharmacoepidemiol Drug Saf. 2003, 12: 221-225. 10.1002\/pds.770.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"24_CR16","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1067\/mob.2003.223","volume":"188","author":"DD Glover","year":"2003","unstructured":"Glover DD, Amonkar M, Rybeck BF, Tracy TS: Prescription, over-the-counter, and herbal medicine use in a rural, obstetric population. Am J Obstet Gynecol. 2003, 188: 1039-1045. 10.1067\/mob.2003.223.","journal-title":"Am J Obstet Gynecol"},{"key":"24_CR17","first-page":"32","volume":"13","author":"LT De Jong-van den Berg","year":"1991","unstructured":"De Jong-van den Berg LT, Berg Van den PB, Haaijer-Ruskamp FM, Dukes MN, Wesseling H: Investigating drug use in pregnancy. Methodological problems and perspectives. Pharm Weekbl Sci. 1991, 13: 32-38.","journal-title":"Pharm Weekbl Sci"},{"key":"24_CR18","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1002\/pds.1235","volume":"15","author":"SE Andrade","year":"2006","unstructured":"Andrade SE, Raebel MA, Morse AN, Davis RL, Chan KA, Finkelstein JA, Fortman KK, McPhillips H, Roblin D, Smith DH, Yood MU, Platt R, H Gurwitz J: Use of prescription medications with a potential for fetal harm among pregnant women. Pharmacoepidemiol Drug Saf. 2006, 15: 546-554. 10.1002\/pds.1235.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"24_CR19","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1517\/14740338.7.2.195","volume":"7","author":"MJ Eadie","year":"2008","unstructured":"Eadie MJ: Antiepileptic drugs as human teratogens. Expert Opin Drug Saf. 2008, 7: 195-209. 10.1517\/14740338.7.2.195.","journal-title":"Expert Opin Drug Saf"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2393-8-24.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2393-8-24\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2393-8-24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,18]],"date-time":"2017-06-18T09:54:47Z","timestamp":1497779687000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/1471-2393-8-24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7,15]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["24"],"URL":"https:\/\/doi.org\/10.1186\/1471-2393-8-24","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7,15]]},"article-number":"24"}}